ArticleVaccines2022

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies.

Chung Y Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.